Market Overview - The chemical pharmaceutical sector experienced a decline of 3.21% on August 27, with Yuyuan Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Stock Performance - Notable gainers included: - Nanjing New Pharmaceutical (688189) with a closing price of 16.98, up 20.00% [1] - Ailisi (688578) with a closing price of 111.31, up 17.00% [1] - Maiwei Biotech (688062) with a closing price of 45.08, up 6.07% [1] - Significant losers included: - Yuyuan Pharmaceutical (688658) with a closing price of 26.45, down 16.82% [2] - Guangshengtang (300436) with a closing price of 124.55, down 10.32% [2] - Lifang Pharmaceutical (003020) with a closing price of 32.31, down 10.00% [2] Capital Flow - The chemical pharmaceutical sector saw a net outflow of 6.417 billion yuan from institutional investors, while retail investors contributed a net inflow of 5.263 billion yuan [2][3] - The table of capital flow indicates that major stocks like Nanjing New Pharmaceutical had a net inflow of 114 million yuan from institutional investors [3]
化学制药板块8月27日跌3.21%,悦康药业领跌,主力资金净流出64.17亿元